The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice

…, S Steinfeld, F Van den Bosch, L Dewulf… - Annals of the …, 2007 - ard.bmj.com
Objectives: This study aimed to describe the epidemiology of ankylosing spondylitis (AS) in
rheumatology practice at the beginning of the anti-TNF (tumour necrosis factor) era, and to …

Partnering with patients in the development and lifecycle of medicines: a call for action

…, J Anderson, M Boutin, L Dewulf… - Therapeutic …, 2015 - journals.sagepub.com
The purpose of medicines is to improve patients' lives. Stakeholders involved in the development
and lifecycle management of medicines agree that more effective patient involvement …

Spinal radiographic changes in ankylosing spondylitis: association with clinical characteristics and functional outcome

…, F Van den BOSCH, H MIELANTS, L Dewulf… - The Journal of …, 2009 - jrheum.org
Objective. To determine which patients with ankylosing spondylitis (AS) have radiographic
spinal damage and to investigate the relation between radiographic spinal changes and …

Position statement from the European Board and College of Obstetrics & Gynaecology (EBCOG): The use of medicines during pregnancy–call for action

…, K Gersak, H Sundseth, I Klingmann, L Dewulf… - European Journal of …, 2016 - Elsevier
… Author links open overlay panel Kristel Van Calsteren a , Ksenija Gersak b , Hildrun
Sundseth c , Ingrid Klingmann d , Lode Dewulf e , André Van Assche a f , Tahir Mahmood f …

Culture and process change as a priority for patient engagement in medicines development

M Boutin, L Dewulf, A Hoos, J Geissler… - Therapeutic …, 2017 - journals.sagepub.com
Patient Focused Medicines Development (PFMD) is a not-for-profit independent multinational
coalition of patients, patient stakeholders, and the pharmaceutical industry with interests …

Medicines in pregnancy—women and children first? Time for a coalition to address a substantial patient need

L Dewulf - Therapeutic Innovation & Regulatory Science, 2013 - journals.sagepub.com
Medical care during and around pregnancy needs better data. Pre-existing medical conditions
(25% and increasing) and intercurrent illnesses cause an estimated 90% of women to …

Is the allergic rhinitis and its impact on asthma classification useful in daily primary care practice?

H Van Hoecke, N Vastesaeger, L Dewulf… - Journal of allergy and …, 2006 - jacionline.org
NS, Not significant.* Statistical analyses with x2 test for trend (Medcalc, version 8.1. 0.0,
Medcalc Software, Mariakerke, Belgium). P<. 05 5 statistically significant.| Each symptom score …

Patient engagement by pharma—why and how? A framework for compliant patient engagement

L Dewulf - Therapeutic Innovation & Regulatory Science, 2015 - Springer
Engagement is increasingly recognized as a decisive factor for health-related outcomes in
people living with a medical issue. It is their experience that drives this engagement. Therefore…

[HTML][HTML] Patient Engagement and Patient Experience Data in Regulatory Review and Health Technology Assessment: A Global Landscape Review

N Bertelsen, L Dewulf, S Ferrè, R Vermeulen… - … Innovation & Regulatory …, 2024 - Springer
Background Working with patients through meaningful patient engagement (PE) and
incorporating patient experience data (PXD) is increasingly important in medicines and medical …

Effect of dropouts in a longitudinal study: an application of a repeated ordinal model

…, G MOLENBERGHS, L DEWULF - Statistics in …, 1996 - Wiley Online Library
An analysis is presented of a longitudinal study of fluvoxamine, an antidepressant drug, with
ordinal responses, regressed on a combination of discrete and continuous covariates and …